Cytek Biosciences (CTKB) Shares Repurchased (2023 - 2025)

Cytek Biosciences (CTKB) has 3 years of Shares Repurchased data on file, last reported at -$34000.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Repurchased fell 100.49% year-over-year to -$34000.0; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 86.21% YoY), and the FY2025 full-year result was $15.1 million, down 30.25% from the prior year.
• Shares Repurchased for Q4 2025 stood at -$34000.0, down from $8000.0 in the prior quarter.
• Across five years, Shares Repurchased topped out at $34.6 million in Q4 2023 and bottomed at -$34000.0 in Q4 2025.
• The 3-year median for Shares Repurchased is $7.0 million (2024), against an average of $8.9 million.
• Peak annual rise in Shares Repurchased reached 67.53% in 2025, while the deepest fall reached 100.49% in 2025.
• A 3-year view of Shares Repurchased shows it stood at $34.6 million in 2023, then slumped by 79.77% to $7.0 million in 2024, then plunged by 100.49% to -$34000.0 in 2025.
• The last three Shares Repurchased figures came in at -$34000.0 (Q4 2025), $8000.0 (Q3 2025), and $4.5 million (Q2 2025), per Business Quant data.

Peer Comparison